#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Graft versus host disease Necrotising myositis Nodal marginal zone B-cell lymphoma Familial dilated cardiomyopathy Rheumatoid arthritis Mantle cell lymphoma recurrent Prostate cancer Pulmonary arterial hypertension Heavy menstrual bleeding Myxoid liposarcoma Gaucher's disease type I Malignant neoplasm of choroid Deafness neurosensory Pneumonia Homocystinuria More trials…

    Learn about Rare Diseases

    Osteosarcoma Hairy cell leukaemia recurrent – Life with Disease Antisynthetase syndrome – Treatment Immunodeficiency congenital – Diagnostics Hepatic angiosarcoma – Treatment Synovial sarcoma metastatic Isodicentric chromosome 15 syndrome – Basic Information Loeys-Dietz syndrome – Trials in Disease Marginal zone lymphoma refractory Rhabdoid tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcifediol Befiradol (18F) Durvalumab Avapritinib Xaluritamig Emrusolmin Cytisine Platelet Concentrate DICLOFENAC POTASSIUM Ipatasertib Omaveloxolone Betula Alba Pollen Extract [14C]ZIPALERTINIB ZILEBESIRAN LTX-002 SODIUM Olmesartan Medoxomil Fluticasone Furoate Lamivudine HRS 9531 Solrikitug More therapies…

    Learn about Your Condition

    Ankylosing spondylitis Endocarditis Endometrial cancer stage III Lung adenocarcinoma stage IV Viral myocarditis Metastatic glioma Pseudoxanthoma elasticum Renal cancer stage IV Thyroid mass Paraganglion neoplasm Pelvic venous thrombosis KBG syndrome Procedural hypotension Hypertension Methylmalonic acidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Mirikizumab for Children and Teens with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Germany Italy The Netherlands +4

  • Study on Edoxaban and Drug Combination for Patients with Atrial Fibrillation Needing Anticoagulation After Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dabigatran
    • Phenprocoumon
    • Rivaroxaban
    Germany

  • Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cytisine
    Poland

  • Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Lonvoguran
    • Ziclumeran
    France Germany The Netherlands

  • Study on the Safety and Effects of ION356 for Patients with Pelizaeus-Merzbacher Disease

    Recruiting

    1 1 1
    Investigated Diseases:
    • Pelizaeus-Merzbacher disease
    Investigated Drugs:
    • 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Plp1 Pre-Mrna
    France Germany The Netherlands

  • Study on Gallium (68Ga) Chloride PET/CT for Detecting Lymph Node Metastasis in Patients with Early Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands
Previous Page
1 … 544 545 546 547 548 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!